NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.2 Drugs affecting the immune response > 8.2.3 Anti-lymphocyte monoclonal antibodies > Follicular lymphoma - rituximab - NICE TAG TA243

Follicular lymphoma - rituximab - NICE TAG TA243

1.1 Rituximab, in combination with:

  • cyclophosphamide, vincristine and prednisolone (CVP)

  • cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP)

  • mitoxantrone, chlorambucil and prednisolone (MCP)

  • cyclophosphamide, doxorubicin, etoposide, prednisolone and interferon-α (CHVPi) or

  • chlorambucil

    is recommended as an option for the treatment of symptomatic stage III and IV follicular lymphoma in previously untreated people.

 

https://www.nice.org.uk/guidance/TA243

Site by Devopa
© Copyright 2019 NHS. All rights reserved.